SIGA Technologies Stock Trading Halted Today; FDA Advisory Committee is Scheduled to Review New Drug Application of TPOXX® Read more about SIGA Technologies Stock Trading Halted Today; FDA Advisory Committee is Scheduled to Review New Drug Application of TPOXX® SIGA Technologies Announces Relisting on Nasdaq Read more about SIGA Technologies Announces Relisting on Nasdaq SIGA Technologies Announces FDA Accepts NDA and Grants Priority Review for Oral TPOXX to Treat Smallpox Read more about SIGA Technologies Announces FDA Accepts NDA and Grants Priority Review for Oral TPOXX to Treat Smallpox SIGA Technologies Announces FDA Submission of its New Drug Application for oral TPOXX (tecovirimat) to Treat Smallpox Read more about SIGA Technologies Announces FDA Submission of its New Drug Application for oral TPOXX (tecovirimat) to Treat Smallpox SIGA to Present at the Cantor Fitzgerald Global Healthcare Conference on September 27, 2017 Read more about SIGA to Present at the Cantor Fitzgerald Global Healthcare Conference on September 27, 2017 SIGA to Present at the Jefferies Global Healthcare Conference on June 9, 2017 Read more about SIGA to Present at the Jefferies Global Healthcare Conference on June 9, 2017 SIGA Completes Enrollment and Dosing in Final Cohort of Phase I Study of IV Formulation of TPOXX® (tecovirimat) to Treat Smallpox Read more about SIGA Completes Enrollment and Dosing in Final Cohort of Phase I Study of IV Formulation of TPOXX® (tecovirimat) to Treat Smallpox SIGA Announces Successful Completion of Rights Offering; Funding of Loan; Completion of Payment of PharmAthene Obligation Read more about SIGA Announces Successful Completion of Rights Offering; Funding of Loan; Completion of Payment of PharmAthene Obligation SIGA Announces Commencement of Rights Offering Read more about SIGA Announces Commencement of Rights Offering SIGA Announces Dr. Phil Gomez Joins Company as New CEO, Dr. Eric Rose to Serve as Executive Chairman of the Board Read more about SIGA Announces Dr. Phil Gomez Joins Company as New CEO, Dr. Eric Rose to Serve as Executive Chairman of the Board Pagination First page « First Previous page ‹ Previous … Page 10 Page 11 Page 12 Page 13 Current page 14 Page 15 Page 16 Page 17 Page 18 … Next page Next › Last page Last » Subscribe to
SIGA Technologies Stock Trading Halted Today; FDA Advisory Committee is Scheduled to Review New Drug Application of TPOXX® Read more about SIGA Technologies Stock Trading Halted Today; FDA Advisory Committee is Scheduled to Review New Drug Application of TPOXX®
SIGA Technologies Announces Relisting on Nasdaq Read more about SIGA Technologies Announces Relisting on Nasdaq
SIGA Technologies Announces FDA Accepts NDA and Grants Priority Review for Oral TPOXX to Treat Smallpox Read more about SIGA Technologies Announces FDA Accepts NDA and Grants Priority Review for Oral TPOXX to Treat Smallpox
SIGA Technologies Announces FDA Submission of its New Drug Application for oral TPOXX (tecovirimat) to Treat Smallpox Read more about SIGA Technologies Announces FDA Submission of its New Drug Application for oral TPOXX (tecovirimat) to Treat Smallpox
SIGA to Present at the Cantor Fitzgerald Global Healthcare Conference on September 27, 2017 Read more about SIGA to Present at the Cantor Fitzgerald Global Healthcare Conference on September 27, 2017
SIGA to Present at the Jefferies Global Healthcare Conference on June 9, 2017 Read more about SIGA to Present at the Jefferies Global Healthcare Conference on June 9, 2017
SIGA Completes Enrollment and Dosing in Final Cohort of Phase I Study of IV Formulation of TPOXX® (tecovirimat) to Treat Smallpox Read more about SIGA Completes Enrollment and Dosing in Final Cohort of Phase I Study of IV Formulation of TPOXX® (tecovirimat) to Treat Smallpox
SIGA Announces Successful Completion of Rights Offering; Funding of Loan; Completion of Payment of PharmAthene Obligation Read more about SIGA Announces Successful Completion of Rights Offering; Funding of Loan; Completion of Payment of PharmAthene Obligation
SIGA Announces Commencement of Rights Offering Read more about SIGA Announces Commencement of Rights Offering
SIGA Announces Dr. Phil Gomez Joins Company as New CEO, Dr. Eric Rose to Serve as Executive Chairman of the Board Read more about SIGA Announces Dr. Phil Gomez Joins Company as New CEO, Dr. Eric Rose to Serve as Executive Chairman of the Board